Drbio, I appreciate your update on Response Biomedical.
Another program that I think adds to the potential value of RBM is flu testing, especially if its sensitivity for avian flu pans out as a way to distinguish itself from the competition. As far as I know, progress in flu testing won't necessarily be part of the 3M collaboration and so deserves separate mention.
Market Data 
Markets 
AI
